ISMPP Highlights
ISMPP’s 2024 European Meeting: Record Attendance Explores Innovation and Tradition in Industry
From January 23-24, ISMPP members gathered together in London for two days of collaboration, networking, learning and sharing. The 2024 European Meeting welcomed a record-high number of attendees with 395 industry professionals gathering at Novotel London West and 155 of those attendees participated in this meeting for their first time!
ACCORD: New Guideline for Consensus-based Research is Published
The new ACCORD reporting guideline will help the medical and scientific communities to improve the reporting of research involving consensus methodologies. The guideline was published last week in PLOS Medicine with simultaneous presentation at the 2024 European Meeting of ISMPP.
ISMPP Announces Artificial Intelligence Position Statement and Call to Action
ISMPP is thrilled to announce that its highly-anticipated ISMPP Position Statement and Call to Action on Artificial Intelligence (AI) was published today, November 1, 2023, in Current Medical Research and Opinion (CMRO)…
Message from Our Leadership
Robert J. Matheis
ISMPP President and CEO
News and Trends
Copyright Confusion: Demystifying Creative Commons Licenses for Industry-Funded Research
Have you ever published a journal article open access? If so, you might be familiar with Creative Commons (CC) licenses. This series of copyright licenses was designed as an alternative to standard copyright models, allowing authors to retain copyright of their work while setting the conditions for the reuse of the work…
What Is Omnichannel in Medical Communications?
Since the term “omnichannel” first emerged in marketing materials around 2010, its use has expanded across many industries. The early 2020s have seen an explosion in the use of the term “omnichannel” in healthcare, including in medical communications and as an evolution of current medical education planning…
Publications Without Borders – Harmonizing Local and Global Planning
Pharma-sponsored publications add to the evidence base and play a crucial role in various activities, including medical education, medical information, marketing, pricing and market access, and regulatory affairs. They also ensure timeliness of transparent data disclosure. At the local level, publications primarily serve specific needs, such as reimbursement activities, filling evidence gaps, or guiding local clinical practice…
What Would You Do?
In our role as medical publication professionals, we may occasionally encounter situations in which it is not obvious how to ensure good publication practice. Have you ever wished you could consult the ISMPP membership for guidance when these situations arise? Here’s your opportunity!
What Would You Do? is a section of The MAP that presents case scenarios as an educational tool for medical publication professionals. The section provides a case scenario to ponder, and readers are invited to participate in a poll by selecting one of the listed solutions. Readers can also submit their thoughts on the scenario anonymously. The poll results, plus educational insights, are posted in a later issue for readers to digest.
Adverse Event Inclusion Just Before Abstract Submission
A medical writer worked with authors to develop a congress abstract for a Phase 2 clinical study. Two days before submission, the lead author requests an additional ‘medical narrative’ statement to be added detailing the management steps and time to resolution of an adverse event seen in one patient. What would you do?
ISMPP (pronounced IzMap) is the only nonprofit organization founded by medical publication professionals for medical publication professionals